Novadip Biosciences
Accelerated Healing | Novadip | Tissue Regenerative Medicine
Novadip Biosciences has 2 recorded funding rounds.
- Website
- novadip.com
- Last Round
- Extension RoundNov 2022
- Rounds
- 2
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
UCLouvain-derived regenerative medicine company developing NVD003 for congenital pseudarthrosis
Summary
Novadip Biosciences is a Biotech company. Its most recent funding was an Extension Round in Nov 2022. Investors include European Investment Bank and CR-CP Life Science Fund.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2023
Sign up to see all 3 events
Funding: Series B through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/novadip-biosciences"><img src="https://indexed.vc/api/badge/company/novadip-biosciences" alt="Novadip Biosciences on Indexed.vc" width="260" height="76" /></a>